CD25, the high-affinity interleukin-2 (IL-2) receptor a chain, is rapidly upregulated by antigen-specific CD8 + T cells after T cell receptor stimulation. Here, we demonstrate that during an acute viral infection, CD25 expression is quite dynamic-after initial upregulation, a subset of virus-specific T cells sustains CD25 expression longer than the rest. At this time when there is distinct heterogeneity in CD25 expression, examination of the in vivo fate of effector cells revealed that CD25 lo cells, which are relatively less sensitive to IL-2, preferentially upregulate CD127 and CD62L and give rise to functional long-lived memory cells. In contrast, CD25
INTRODUCTION
After antigen encounter, naive CD8 + T cells undergo extensive proliferation and differentiate into effector cells. Several studies now confirm that an initial encounter with antigen launches CD8 + T cells into a ''program'' of proliferation and effector differentiation (Kaech and Ahmed, 2001; Kalia et al., 2006; Mercado et al., 2000; van Stipdonk et al., 2003; van Stipdonk et al., 2001; Williams and Bevan, 2007) . Moreover, the onset and kinetics of contraction and memory CD8 + T cell fate are also programmed (Badovinac et al., 2002; Kaech and Ahmed, 2001) . Programming implies that quality, quantity, and context of the initial signal impact CD8 + T cell fate. However, defining the precise signals that promote differentiation of effector and memory CD8 + T cells has been challenging, due to a lack of molecular markers that effectively distinguish memory fated cells (memory precursors [MP] ) from end-stage effectors (terminal effectors [TEs] ). An increased impetus in this area in recent years has led to the delineation of several markers (IL-7Ra, CD62L, IL-2, and KLRG-1) (Joshi et al., 2007; Kaech et al., 2003; Marzo et al., 2005; Sarkar et al., 2008; Wherry et al., 2003) that can effectively distinguish MP from TE cells. The presence of KLRG-1 int memory fated cells in the pool of expanding CD8 + T cells suggests that signals that promote memory differentiation are received during the priming phase of the immune response and allows one to explore the signals and mechanisms regulating the generation of these subsets. Various signals, including the strength and duration of infection and T cell receptor (TCR) stimulation, activation status and type of antigen-presenting cells, costimulation, CD4 + T cell help, inflammatory cytokines, and growth factors are implicated in regulating T cell fate decisions Kalia et al., 2006; Williams and Bevan, 2007) . Curtailing the duration of antigen promotes the differentiation of long-lived lymphoid memory cells (Sarkar et al., 2008) . However, TCR signals are not solely responsible for the diverse fates of responding T cells. Among various environmental cues, the role of IL-2 in impacting T cell responses has been extensively investigated (Gillis et al., 1978; Lenardo, 1991; Malek, 2008; Pandiyan et al., 2007; Smith, 1988) . Although originally defined as a positive growth factor for T cells, IL-2 can exert both positive and negative effects (Cousens et al., 1995; Sadlack et al., 1993; Suzuki et al., 1995) . Previous studies involving Il2 À/À or Il2ra À/À mice were complicated by development of autoimmunity, but a recent study employed a mixed chimera strategy, in which T cells lacking the high-affinity IL-2Ra were followed in a wild-type environment (Williams et al., 2006) . Although the number of developing effector and memory cells was not affected by the lack of IL-2Ra, secondary responses of CD8 + T cells were compromised, thus leading to the conclusion that IL-2 signals are important in programming memory cells with robust recall responses. With the goal of evaluating the requirement of IL-2 during different stages of CD8 + T cell differentiation, other studies employed the strategy of in vivo IL-2 administration (Blattman et al., 2003; . This approach demonstrated that excessive IL-2 signals during priming and expansion resulted in increased contraction, whereas IL-2 administration during contraction led to enhanced cell survival. Although, both approaches demonstrated a role of IL-2 in modulating CD8 + T cell responses, the precise effect of IL-2 (positive or negative) on memory and the timing of IL-2 action remain to be clearly defined.
In this study, we have examined the role of IL-2 signals in CD8 + T cell differentiation by using the mouse model of acute infection with lymphocytic choriomeningitis virus (LCMV). Our results show that IL-2 plays a major role in CD8 + T cell programming and that prolonged IL-2 signals promote terminal-effector differentiation in vivo.
RESULTS

Dynamic Expression of IL-2R a, b, and g Chains during CD8 + T Cell Priming
To better understand the role of IL-2 signals in programming CD8 + T cell responses, we performed a longitudinal analysis of the expression of IL-2 receptor on virus-specific cells after an acute LCMV infection. The high-affinity IL-2R is a heterotrimer of CD25, the high-affinity IL-2Ra chain, the IL-2Rb (CD122), and the common g-chains (CD132) (Malek, 2008) . CD25 imparts high-affinity binding to IL-2, whereas the b-and the g-chains serve to efficiently transduce IL-2 signals via signaling motifs in their cytoplasmic tails. CD25 expression was uniformly induced on antigen-specific CD8 + T cells early after infection (days 1-2). Additionally, CD25 induction increased with increasing rounds of cell division, as delineated by CFSE dilution ( Figure 1A ). Approximately day 3.5 after infection, a subset of antigen-specific T cells selectively downregulated their expression of CD25, such that two distinct populations of CD25 lo and CD25 hi cells were discernable (Figures 1A and 1B) . Subsequently, at day 5 after infection, when antigen is largely cleared from the system, all antigen-specific CD8 + T cells downregulated CD25 expression ( Figure 1B ). Similar to the IL-2Ra chain, the b-and g-chains were also upregulated after TCR stimulation in a cell division-dependent manner (Figure 1A) . After antigen clearance, CD122 and CD132 expression decreased slightly, but was maintained at higher than naive amounts and no heterogeneity in CD122 and CD132 expression was found, as was the case with CD25. It is noteworthy that the heterogeneity in CD25 expression was observed not only with higher precursor frequencies of transgenic CD8 + T cells ( Figures  1A and 1B ) but was also seen at lower precursor frequencies (10 2 antigen-specific cells), as well as in endogenous GP33, NP396, and GP276 tetramer-specific cells in B6 mice ( Figures  1C and 1D ). This observed heterogeneity in CD25 expression is suggestive of IL-2 playing a role in differential programming of CD8 + T cells. (Malek, 2008) . To understand if IL-2 may be regulating the heterogeneity in CD25 expression, we measured the amount of IL-2 in spleens of mice infected with LCMV at different days after infection. This analysis was done in B6 mice, and also in mice that received P14 transgenic CD8 + T cells. In both cases, peak of CD25 expression followed the peak of splenic IL-2 production ( Figures 1A, 1B , and 2A and Figure S1 available online). Manifestation of CD25 heterogeneity correlated with a substantial drop in splenic IL-2 concentrations; in the case of P14 chimeric mice, CD25 heterogeneity was evident at day 3.5 and IL-2 concentrations dropped down to near basal amounts at this time point (Figures 1A, 1B, and 2A) . Similarly, in the case of B6 mice, CD25 heterogeneity at day 5 correlated with decreased IL-2 amounts at day 5 in the spleen (Figures 1C, 1D, and 2A) . These data provide correlative evidence that CD25 heterogeneity may result from differential IL-2 signals under conditions of limiting IL-2. When we blocked IL-2 signals from days 0-3.5 postinfection, we found a decrease in the CD25 expression compared to untreated controls ( Figure 2B ). Thus, IL-2 signals appear to be important in regulating CD25 expression and heterogeneity. To determine whether higher CD25 expression correlated with increased IL-2 signaling, we tested the ability of CD25 hi and CD25 lo cells to induce phosphorylation of STAT-5 after in vitro or in vivo IL-2 stimulation. In both cases of in vitro ( Figure 2C ) and in vivo ( Figure 2D ) stimulation, we found that CD25 hi cells transduced IL-2 signals more efficiently than CD25 lo cells, such that $2-fold greater STAT5 phosphorylation (fold-over unstimulated) was observed in CD25 hi cells ( Figures 2C and 2D ). These results demonstrate that activated CD8 + T cells that express relatively more cell surface CD25 are more efficient at perceiving and transducing IL-2 signals.
CD25 Heterogeneity Is Associated with Differential Expression of Effector Molecules
To investigate whether the CD25 lo and CD25 hi virus-specific CD8 + T cells discernable at 3.5 days after infection may have assimilated differential signals, we next evaluated their phenotypic and functional properties (Figure 3 ). Both subsets were activated as demonstrated by similar CD44 upregulation relative to naive cells. Both subsets also downregulated CD127 and CD62L, and upregulated KLRG-1 expression similarly (Figure 3A) . We observed that at the mRNA level, CD25 hi cells exhibited more pronounced downregulation of CD62L, CD127, and CCR7 ( Figure 3B and 3C), suggesting enhanced effector differentiation. Consistent with this possibility, CD25 hi cells expressed modestly higher amounts (1.4-fold) of intracellular granzyme B ( Figures 3B and 3C ). Moreover, mRNA of granzymes ( Figure 3B ) and perforin ( Figure 3C ) were also higher in CD25 hi cells. Despite modestly lower expression of effector genes in CD25 lo cells, both subsets exhibited largely similar direct ex vivo killing activity ( Figure 3D ), demonstrating that both CD25 hi and CD25 lo cells had differentiated into equally potent killer cells. T-bet is an important regulator of effector differentiation, and increased T-bet expression correlates with terminaleffector differentiation during later stages of the immune response ( Figure S2 ). Consistent with their effector differentiation status, CD25 hi and CD25 lo subsets had similarly upregulated T-bet expression by $50-fold compared to naive cells ( Figures  3B and 3C ). The production of effector cytokines, IFN-g and TNF-a after in vitro peptide stimulation, was also largely similar in both subsets ( Figure 3E ), although IFN-g mRNA expression was slightly elevated in CD25 hi cells ( Figure 3B ). IL-2 production is typically associated with naive and central memory cells and is progressively lost in CD8 + T cells with advanced effector differentiation (Badovinac and Harty, 2006; Sarkar et al., 2008; Intlekofer et al., 2007; Wherry et al., 2003) . Consistent with this, we observed that CD25 hi cells produced substantially lower amounts of IL-2 compared to the CD25 lo cells ( Figure 3E Figure 4A ). This ensured that all environmental cues were maintained similarly to the donor mice, and the donor subsets only differed in their cell intrinsic properties associated with differential CD25 expression. First, we examined the ''take'' of both subsets by quantifying the CD25 lo and CD25 hi donor cells in various lymphoid and nonlymphoid tissues 8 hr after adoptive transfer. Overall, the total number of engrafted donor cells was largely similar for CD25 lo and CD25 hi subsets at 8 hr after transfer ( Figure S3 ). However, modestly higher numbers of CD25 lo cells localized in the lymph nodes, and CD25 hi donors exhibited a slight enrichment in peripheral lung and liver tissues.
In order to follow early proliferation of the segregated effector subsets, the sorted donor cells were labeled with CFSE prior to adoptive transfer, and the extent of CFSE dilution was analyzed at days 1.5 and 5 after transfer. Analysis of CFSE dilution at day 1.5 revealed that CD25 hi donor cells were dividing more rapidly than the CD25 lo cells ( Figure 4B ). In all tissues examined, CD25 hi cells had diluted CFSE more than CD25 lo cells and exhibited at least one extra division. This greater proliferation of CD25 hi cells correlated with an increased number of CD25 hi cells ($5-fold higher) in all tissues examined, compared to CD25 lo cells at 1.5 day after transfer ( Figure 4B ). By day 5 after transfer, both subsets had completely diluted the CFSE, demonstrating that both subsets had divided >10 rounds after transfer ( Figure 4C ). At this time, the cell number ratios of CD25 lo and CD25 hi donors were reversed, such that absolute numbers of CD25 lo cells were 2-to 5-fold greater than CD25 hi cells in all tissues examined ( Figure 4C ). The decreased numbers of CD25 hi donor cells correlated with increased apoptosis of CD25 hi cells compared to CD25 lo cells ( Figure 4D ). Greater frequency of Annexin V + CD25 hi cells was observed at days 1.5 and 5.0 after transfer ( Figure 4D and data not shown). These data demonstrate that CD25 hi cells undergo greater extent of proliferation immediately after transfer, but are also more prone to apoptosis. We next analyzed the expression of granzyme B and KLRG-1 on donor cells after adoptive transfer ( Figure 4E ). Increased expression of granzyme B and KLRG-1 is associated with effector CD8
+ T cells that are more advanced in their differentiation status (Sarkar et al., 2008) . We observed increased generation of KLRG-1 hi TE cells from CD25 injections at days 0-3. The second control group was injected with PBS. Mice were sacrificed at day 3.5 after infection, and CD25 expression was analyzed on CD8 + Thy1.1 + cells from spleen, inguinal lymph nodes (iLN), lung, and liver. Representative flow cytometry plots from two independent experiments; n = 3 are presented.
(C) CD8 + T cells expressing low or high amounts of CD25 were purified and stimulated in vitro with indicated doses of r-hIL-2 for 15 min. Phosphorylation of STAT5
was assessed by flow cytometry and mean fluorescence intensity (MFI) of pSTAT5 is presented in red.
(D) P14 chimeric mice, containing 1 3 10 6 GP33-specific transgenic cells, were injected with r-hIL-2 after 3.5 days of acute infection. Mice were sacrificed 15 min later, and intracellular p-STAT5 was assessed by flow cytometry. Day 3.5-infected mice that were administered PBS alone were used as a source of unstimulated cells. Histogram plots are representative of two independent experiments; n = 3 for in vitro and in vivo were not coated with peptide (À Peptide) were used as negative controls.
(E) Splenocytes were isolated from P14 chimeric mice at day 3.5 after LCMV infection. CD8 + T cells expressing high and low CD25 were purified and stimulated in vitro with GP33 peptide for 5 hr in the presence of brefeldin A. IFN-g, TNF-a, and IL-2 production was assessed thereafter by intracellular cytokine staining. Unstimulated cultures were used as negative controls (gray histograms). Data presented are representative of three different experiments with two to three mice per group. IL-2 and Programming of CD8 + T Cell Memory followed acquisition of key memory properties such as long-term maintenance of donor cells, upregulation of lymph node-homing marker CD62L, IL-2 production, and recall proliferation potential.
The kinetics of donor cell expansion, contraction, and maintenance were determined by assessment of CD8 + Thy1.1 + donor cells longitudinally ( Figure 5A ) in blood and in various tissues at day 180 after transfer ( Figure 5B ). After adoptive transfer, both CD25 hi and CD25 lo subsets underwent substantial expansion. However, consistent with data in Figure 4B , CD25 hi cells apparently exhibited enhanced expansion during first 2 days after transfer. With respect to memory outcome, as predicted by preferential generation of KLRG-1 int MP cells from CD25 lo cells, the CD25 lo donors persisted at $5-fold higher numbers than CD25 hi donors in blood after contraction ( Figure 5A ). Similarly, CD25 lo donor cells gave rise to $5-fold higher absolute numbers of long-lived memory cells in all lymphoid and nonlymphoid tissues tested ( Figure 5B and Figure S4A ). L-selectin is classically employed as a key memory marker that distinguishes long-lived memory cells capable of preferential migration to lymph nodes. We found that CD25 lo donor cells not only exhibited preferential survival into memory phases but were also capable of upregulating CD127 and L-selectin, phenotypic markers associated with long-lived memory cells, more efficiently than CD25 hi donor cells after antigen clearance ( Figure 5C and Figure S4B ). Although the majority of CD25 lo donor cells had upregulated CD62L expression by day 120 after transfer, the few CD25 hi donor cells that survived into memory phases exhibited a compromised ability to upregulate CD62L and CD127. Consistent with higher CD62L expression, memory cells arising from CD25 lo donor cells also exhibited increased localization in lymph nodes compared to CD25 hi donor cells ( Figure S4C ).
In addition to more efficient acquisition of classic memory phenotype by CD25 lo donor cells, these cells also exhibited various functional attributes of optimal memory cells. Although both donor subtypes produced similar amounts of IFN-g and TNF-a, memory cells arising from CD25 lo donors were capable of superior IL-2 production, compared to memory cells from CD25 hi donors ( Figure 5D ). Figure 6A ). However, in the absence of further TCR and IL-2 signals, the numbers of CD25 hi and CD25 lo donor cells did not continue to increase until day 5 after transfer, as was the case with infection-matched recipients. Contraction ensued day 1 after transfer, and after contraction CD25 hi cells persisted at $5-fold higher numbers than CD25 lo cells in the blood. Similarly, CD25 hi donor cells were present at 5-to 10-fold higher numbers than CD25 lo cells in all tissues analyzed (spleen, inguinal and brachial lymph nodes, lung, and liver) ( Figures 6B and 6C ). The higher numbers of CD25 hi donor cells at memory correlated with higher numbers at day 1 after adoptive transfer. This is consistent with data in Figure 4 in which CD25 hi cells were found to undergo rapid prolif- Figure 6D ). Functionally, memory cells arising from CD25 hi donor cells produced less IL-2 compared to CD25 lo donors when transferred into LCMV immune mice or infection-matched recipients ( Figure 6E ).
Collectively, these studies demonstrate that the heterogeneity in CD25 expression marks a differential memory program in effector cells, such that CD25 lo effectors differentiate into longlived functional memory cells that upregulate CD62L, produce IL-2, and mount a robust recall response. In contrast, effector cells that maintain CD25 expression for longer periods are driven toward terminal differentiation and give rise to memory cells with suboptimal functional properties.
Prolonged IL-2 Signals Contribute to Terminal-Effector Differentiation
To directly test the hypothesis that prolonged IL-2 signals drive terminal-effector differentiation, we exogenously administered high doses of IL-2 (30,000 U/mouse/day) during the expansion T cell differentiation will be skewed toward terminal-effector cell fate. Both GP33-and NP396-specific CD8 + T cells from IL-2-treated mice expressed higher amounts of granzyme B in all tissues examined, compared to untreated control mice ( Figures 7A and 7B ). These data are consistent with increased granzyme B expression by CD25 hi cells and demonstrate increased effector differentiation in presence of enhanced IL-2 signals. Moreover, consistent with previous reports (Blattman et al., 2003) , IL-2 treatment during the expansion phase resulted in increased CD8 + T cell expansion and contraction as depicted by antigen-specific CD8 + T cell numbers at peak of expansion (day 8) and after contraction (day 15) (Figure S5 ). These observations are similar to data in Figure 5 , in which CD25 hi cells capable of receiving enhanced IL-2 signals tend to expand and contract more than their CD25 lo counterparts.
Genome-wide Microarray Analysis of Effector Cells Programmed toward Memory versus Terminal-Effector Fates
The evident differences in functional properties and memory fates of CD25 lo and CD25 hi CD8 + T cells prompted us to perform a genome-wide microarray analysis of both subsets to delineate in detail the genes that are differentially expressed. This knowledge may be useful in understanding the early signals that are important in driving TE versus MP lineage choices. Thus, we purified CD25 lo MP and CD25 hi TE CD8 + T cells from day 3.5 and performed gene chip analyses of both subsets, relative to naive cells. genes relative to naive cells, and CD25 lo CD8 + T cells had upregulated or downregulated the expression of $3786 genes compared to naive cells. Between both subsets, $720 genes were differentially expressed. Out of these 720 differentially regulated genes, 530 genes were expressed at relatively higher levels in CD25 lo cells compared to CD25 hi cells.
Compared to naive cells, both CD25 lo and CD25 hi CD8 + T cells upregulated the expression of several effector genes including granzymes A, B, C, M, and K, IFN-g, T-bet, eomesodermin, and Blimp-1. However, it is noteworthy that CD25 hi cells expressed modestly higher amounts of most of these effector genes ( Figure 3 and Table S1 ). Stress proteins (heat-shock proteins, growth arrest 5) were also expressed at higher amounts in CD25 hi cells. Consistent with the observation that CD25 hi cells divide more, CD25 hi cells expressed cell cycle genes to a higher extent compared to CD25 lo cells (proliferation-associated 2G4, S-phase kinase-associated protein 2) ( Figure S6A and Table S1 ). Although effector genes were expressed at higher amounts in CD25 hi cells, genes that are known to repress terminal differentiation (Bcl6) were expressed at higher amounts in CD25 lo cells (Table S1 ). As expected for effector cells, both subsets had also downregulated lymph node-homing molecules CD62L and CCR7, as well as IL-7Ra, albeit to different levels-CD25 hi cells exhibited increased downregulation of Cd62l, Ccr7, and Cd127 compared to CD25 lo cells. Combined with the observations of similar CTL potential of CD25 lo and CD25 hi cells, these analyses demonstrate that similar to TE cells, memory-fated CD8 + T cells also pass through an effector phase. MP cells exhibited increased expression of several cell survival genes, including Bcl-2, Parp-3, and Spi-2a, as well as key players of signaling networks involved in promoting cell survival (Jak1, which acts upstream of AKT, and Cd40 and Relb, participating in alternative NF-kB pathway induction) (Table S1 ). These observations are consistent with increased survival of CD25 lo memory precursors following adoptive transfer.
Several pathways of innate signaling were found to be higher in MP cells than TE cells ( Figure S6B and Table S1 ). The innate genes and pathways that were selectively overexpressed in MP cells compared to TE cells included (1) type I interferon pathway, such as Jak1, Stat1, Ifit1, feron induced protein with tetratricopeptide repeats); (2) IL-6 signaling pathway including Il-6r and IL-6 signal transducer; (3) direct expression of Toll-like receptors Tlr-1 and Tlr-3, which are typically expressed on cells of the innate immune system; (4) TNF signaling pathway genes including Traf1 (TNF-receptor associated factor 1), Tnfaip8l2, and Traf3ip3; and (5) NF-kB signaling (Pkr, Pkc, Malt1, and Relb) . Such a concerted overexpression of genes involved in innate signaling in MP relative to TE cells is consistent with the known function of innate signals in promoting effector differentiation.
DISCUSSION
Previous reports have demonstrated the significance of IL-2 signals in modulating CD8 + T cell responses. However, evidence exists in favor of both positive and negative impact of IL-2 on CD8 + T cell memory development (Blattman et al., 2003; Williams et al., 2006) . By following the kinetics of CD25 expression in vivo after LCMV infection, and by determining the fate of CD8 + T cells expressing differential levels of CD25, our studies reconcile both reports. Consistent with the proposal of Williams et al. (2006) that IL-2 signals are important for the generation of functional memory cells, we find that early after infection, all CD8 + T cells upregulate the expression of high-affinity IL-2Ra similarly. These cells are thus capable of perceiving IL-2 signals in vivo, which may be crucial for antigen-independent expansion (Kaech and Ahmed, 2001) , effector cell differentiation, and possibly programming of memory potential. Thereafter, a transient heterogeneity in CD25 expression appears, which correlates with differential memory outcomes-cells that are capable of perceiving prolonged IL-2 signals are represented less in the long-lived memory pool, whereas cells that downregulate CD25 earlier preferentially contribute to the long-lived functional lymphoid memory pool. Consistent with previous reports (Blattman et al., 2003) , CD25
hi cells that retain elevated expression of CD25 longer tend to undergo enhanced expansion that is coupled with greater cell death. This is largely governed by the duration of IL-2 and other infection-related stimuli (antigen and inflammation, for example), such that prolonged stimulation drives CD25 hi cells toward terminal-effector differentiation. These data are supportive of a linear continuum of effectors that differentiate into lymphoid memory cells, nonlymphoid memory cells, or terminal effectors on the basis of the degree of stimulation perceived. How is CD25 expression regulated? The expression kinetics of CD25 follows viral replication. At days 1-2 after infection, when virus is replicating exponentially, all virus-specific cells are likely to encounter antigen. This prediction is consistent with uniform upregulation of CD25 expression by antigenspecific CD8 + T cells. Thereafter, at around day 3.5-4 after infection, when antigen-specific CD8 + T cells have greatly expanded and antigen is decreasing, stochastic encounter of a subset of T cells with limiting antigen may be responsible for heterogeneous expression of CD25. Finally, around day 6 after infection, when antigen is largely cleared from the system, CD25 expression is uniformly downregulated on antigen-specific CD8 + T cells. CD25 hi cells may also selectively localize to antigen-rich niches, thus maintaining higher CD25 expression. IL-2 signals can also directly upregulate CD25 expression. Whereas CD25 expression is regulated by the TCR via an NF-kB site just near the start site, after IL-2 is produced CD25 expression is augmented $10-to 20-fold via tandem STAT5 sites that are $9000 bp upstream (Malek, 2008; Smith and Cantrell, 1985) . Therefore, the level of CD25 expression is markedly dependent upon the availability and concentration of IL-2. This is supported by our kinetics of splenic IL-2 expression. Additionally, in vivo administration of IL-2 leads to increased CD25 expression on CD8 + T cells (V.K., S.S., and R.A., data not shown, and Blattman et al., 2003) . Thus, the observed in vivo heterogeneity in CD25 expression probably results from a combination of differential TCR and IL-2 signals, both an integral part of an acute infection. The distinct memory outcomes associated with CD25 hi and CD25 lo effectors clearly correlates with differential IL-2 signaling. This is demonstrated by enhanced phosphorylation of STAT5 in CD25 hi cells both in vitro and in vivo. Moreover, consistent with previous reports that Blimp-1 expression is upregulated by increased IL-2 signals (Calame, 2008; Gong and Malek, 2007; Malek, 2008) , and that Blimp-1 drives terminal-effector differentiation (Rutishauser et al., 2009) demonstrate that Blimp-1 directly represses IL-2 and the IL-2 activator Fos. Consistent with this, CD25 hi cells that express higher levels of Blimp-1 are significantly impaired in their ability to produce IL-2. Greater granzyme B expression by CD25 hi cells is also consistent with increased IL-2 signaling (Janas et al., 2005) . In contrast, correlating with their enhanced ability to produce IL-2, CD25 lo cells express higher levels of Bcl-6, a key negative regulator of Blimp-1. It is likely that enhanced Bcl-6 expression by MP cells compared to TE cells may exert a role in preventing terminal differentiation in memory fated cells (Manders et al., 2005) . How IL-2 signals drive terminal differentiation is intriguing. An accompanying article by Pipkin et al. (2010) in this issue of Immunity demonstrates that enhanced expression of perforin by highdose IL-2 is associated with Stat5 and Eomesodermin recruitment to the Prf1 locus. It is interesting to speculate whether enhanced IL-2 signals may directly impact CD127 and CD62L reacquisition via epigenetic silencing of the loci or regulation of transcription factors, in addition to promoting the expression of effector genes.
Delineation of MP and TE cells early during an immune response provides us with a tool to further understand the signals that program memory fates. Consistent with previous observations in the field, this early analysis of MP and TE subsets confirms that superior IL-2 production is a unique property of MP cells at different times of differentiation (Joshi et al., 2007; Kaech et al., 2003; Marzo et al., 2005; Sarkar et al., 2008; Wherry et al., 2003) . CD8 + T cells have been shown to undergo asymmetric cell division such that unequal apportioning of proteins occurs during the first cell division after priming (Chang et al., 2007) , which correlates with differential cell fates. Interestingly, the differences in expression of granzyme B and CD62L between CD25 hi and CD25 lo effectors shows a similar trend as the proximal and distal daughter cells that arise after the first round of cell division. Additionally, our gene chip analyses reveal a coordinately enhanced expression of innate pathways in MP cells compared to TE cells. This suggests that memory cells differentiate from effector cells and is consistent with the proposal that (Kolumam et al., 2005; Pulendran and Ahmed, 2006 ) direct action of type I interferons on CD8 + T cells promotes CD8 + T cell expansion and survival, thus resulting in the generation of a stable pool of memory T cells. Collectively, our studies provide insights into the timing and mechanism of action of IL-2 signals in regulating T cell effector and memory differentiation. This information may be useful in rational vaccine design and development of immunotherapeutic strategies.
EXPERIMENTAL PROCEDURES
Mice, Virus, and Infections C57BL/6 mice (Thy1.2 + or Thy1.1 + ) were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Thy1.1 + P14 mice bearing the Db-gp33-specific TCR were fully backcrossed to C57BL/6 and maintained in our animal colony. LCMV Armstrong (LCMV Arm ), and recombinant vaccinia virus that expresses the GP33 epitope of LCMV (VV-GP33) were propagated, titered and used as described (Kaech et al., 2002; Sarkar et al., 2008) . All mice were used in accordance with NIH and the Emory University Institutional Animal Care and Use Committee guidelines.
IL-2, Antibodies, Flow Cytometry, and Intracellular Cytokine Staining Recombinant human IL-2 used for CD8 + T cell stimulation was kindly provided by K.A. Smith (Cornell University, New York). IL-2 estimation in spleen was performed by Assaygate (Ijamsville, MD, USA). MHC class I peptide tetramers were made and used as described previously (Murali-Krishna et al., 1998) . Antibodies and procedures for flow cytometric analysis of surface or intracellular proteins and cytokines have been described previously (Kaech et al., 2002; Sarkar et al., 2008) . Intracellular phospho-STAT5 analysis was performed as described previously (Kersh et al., 2003; Krutzik et al., 2005a; Krutzik et al., 2005b venously into infection-matched or LCMV-immune C57BL/6 mice. Donor cells were distinguished with Thy1.1 mAb and isolated from spleen, lymph node, liver, lung, and blood as described (Sarkar et al., 2008) . Cells were labeled with CFSE for analyzing cell proliferation after adoptive transfer (Molecular Probes) as described previously (Kaech et al., 2002; Sarkar et al., 2008) . GP33-41-specific CTL activity was determined by a 5hr 51
Cr-release with purified CD25 lo and CD25 hi effector populations (Kaech et al., 2002) . For analyzing the recall proliferation potential of donor cells, memory cells arising from CD25 lo and CD25 hi sorted effectors were isolated from spleens of recipient mice by column purification of CD8 + cells. For ensuring minimal contamination with endogenous cells, a second round of negative purification was performed with a Thy1.2 column.
Microarray Hybridization and Analysis
Naive, memory and day 3.5 CD25 lo and CD25 hi Thy1.1 + P14 CD8 + T cells were FACS sorted, and RNA was isolated, amplified, and biotinylated as described previously (Kaech et al., 2002; Sarkar et al., 2008) . Samples were hybridized on mouse 430.2 Affymetrix microarray chips (Santa Clara, CA, USA) at the Vanderbilt Microarray Shared Resource (Vanderbilt University, TN, USA) in accordance with the manufacturer's protocols. Raw data were normalized with RMA package built within Genespring 7.0 (Agilent Technologies, Santa Clara, CA, USA) and fold-change comparisons between indicated groups were subsequently made. Pathway analysis was performed with the Ingenuity platform from Ingenuity Systems (Redwood City, CA, USA).
RT-PCR Analysis
Naive, memory, day 3.5 CD25 lo and CD25 hi and day 8.0 effector Thy1.1 + P14 CD8 + T cells were FACS sorted and RNA was isolated from cells in Trizol (GIBCO/BRL Life Technologies, Rockville, MD) according to the manufacturer's protocol. cDNA was synthesized using SuperScript Choice cDNA synthesis kit (GIBCO/BRL). Primers for RT-PCR to quantitate mRNA levels of perforin, granzyme B, T-bet, Blimp-1, CD127, CD62L and CD25 were obtained from QIAGEN (Valencia, CA) and RT-PCR performed according to their recommended protocol.
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